Article Information
History
- March 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Hakim Ghani1,*,
- Michael Shaw, MBBS1,
- Phyoe Pyae, MBBS1,
- Rigers Cama, MBBS1,
- Meghna Prabhakar, MBBS1,
- Alessio Navarra, MBBS1,
- Rahul Mogal, MBBS1,
- Andrew Barlow, MSc1,
- Nazril Nordin, PhD2,
- Rama Vancheeswaran, PhD1,
- Janice Yu Ji Lee, MBBS3 and
- Felix Chua, PhD4
- 1Respiratory Department, West Herts NHS Trust, Watford, UK
- 2Intensive Care, West Herts NHS Trust, Watford, UK
- 3Radiology Department, Addenbrookes Hospital, Cambridge, UK
- 4Respiratory Department, Royal Brompton and Harefield NHS Trust, London, UK
- ↵*Corresponding author:
Hakim Ghani1, Respiratory Department, West Herts NHS Trust, Vicarage Road, Watford WD18 0HB, UK. Email: h.ghani{at}nhs.net, Tel 07366079110
Posted March 24, 2021.
Evaluation of the ROX index in SARS-CoV-2 Acute Respiratory failure treated with both High-Flow Nasal Oxygen (HFNO) and Continuous Positive Airway Pressure (CPAP)
